Physician profile
Noah D Weiss
NPI 1225126444
$261,872.31
in general payments reported to CMS, 2019-2025
22 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,911 · 2020: $186K · 2021: $8,911 · 2022: $35K · 2023: $8,360 · 2024: $7,326 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $18K · Consulting Fee: $7,505 · Food and Beverage: $1,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $17,706.91 |
| Consulting Fee | $7,505.34 |
| Food and Beverage | $1,795.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $239,046.48 | 2020-2025 | Atlas |
| Trice Medical, INC. | $11,248.24 | 2019-2022 | |
| Moximed, INC | $5,780.20 | 2025 | Misha Knee System, Small, Left |
| Stryker Corporation | $2,860.12 | 2024-2025 | Blueprint Patient Specific Instrumentation, Iconix, Variax |
| Parcus Medical, LLC | $1,350.00 | 2020 | |
| Tenex Health INC. | $439.70 | 2021 | |
| Smith+Nephew, INC. | $212.96 | 2024-2025 | Aetos Shoulder System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Axogen | $175.81 | 2019-2023 | Avance Nerve Graft |
| Wright Medical Technology, INC. | $140.35 | 2019-2020 | |
| Miach Orthopaedics, INC. | $137.64 | 2023 | |
| Integra Lifesciences Corporation | $121.03 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $61.97 | 2025 | Comprehensive Shoulder System, Persona |
| Bioventus LLC | $46.63 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Ermi LLC | $46.02 | 2020-2021 | |
| Galderma Laboratories, L.P. | $38.59 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $35.03 | 2019 | |
| Evolution Surgical, INC | $30.84 | 2022 | |
| Medacta USA, INC. | $29.72 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $22.87 | 2025 | |
| Orthofix Medical, INC. | $22.52 | 2025 | Physio-Stim |
| Allergan, INC. | $14.71 | 2020 | |
| Derma Sciences, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$559,411.08 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.